Verona Pharma Drug Patent Portfolio

Verona Pharma owns 1 orange book drug protected by 3 US patents Given below is the list of Verona Pharma's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10945950 Liquid inhalation formulation comprising RPL554 15 Sep, 2035
Active
US9956171 Liquid inhalation formulation comprising RPL554 15 Sep, 2035
Active
US9062047 Crystalline form of pyrimido[6,1-A] isoquinolin-4-one compound 21 Aug, 2031
Active


Verona Pharma's Family Patents


Family Patents



Verona Pharma Drug List

Given below is the complete list of Verona Pharma's drugs and the patents protecting them.


1. Ohtuvayre

Ohtuvayre is protected by 3 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10945950 Liquid inhalation formulation comprising RPL554 15 Sep, 2035
(10 years from now)
Active
US9956171 Liquid inhalation formulation comprising RPL554 15 Sep, 2035
(10 years from now)
Active
US9062047 Crystalline form of pyrimido[6,1-A] isoquinolin-4-one compound 21 Aug, 2031
(6 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ohtuvayre's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Verona Pharma News

GSK's asthma medication receives FDA authorization for the treatment of 'smoker's lung' - Yahoo News Singapore

22 May, 2025

GSK's asthma medication Nucala receives FDA approval for the treatment of 'smoker's lung' - TradingView

22 May, 2025

GSK's asthma medication receives FDA authorization for the treatment of 'smoker's lung' - TradingView

22 May, 2025

See More